Home
Programmes
Evidence
Quiz
Get Started
Evidence
Our programmes are designed by medical professionals and are backed up by clinical studies that prove the efficacy of our chosen treatment paths.
The effects of treatment with liraglutide on quality of life and depression in young obese women with PCOS and controls
Read More
The role of GLP-1 receptor agonists as weight loss agents in patients with and without type 2 diabetes
Read More
Semaglutide as a promising antiobesity drug
Read More
Role of glucagon-like peptide 1 receptor agonists in management of obesity
Read More
Efficacy of High-Dose Liraglutide as an Adjunct for Weight Loss in Patients with Prior Bariatric Surgery
Read More
Reversal of Long-Term Weight Regain After Roux-en-Y Gastric Bypass Using Liraglutide or Surgical Revision. A Prospective Study
Read More
Liraglutide and obesity: a review of the data so far
Read More
Liraglutide: A Review of Its Use in the Management of Obesity
Read More
Liraglutide: A New Option for the Treatment of Obesity
Read More
Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study
Read More
What are the effects of once‐daily Liraglutide when used to treat obesity?
Read More
What are the effects of once‐weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity?
Read More